Communities randomly assigned to less frequent antibiotic use had significantly lower prevalence of genetic antibiotic resistance determinants.
Procalcitonin-guided therapy did not reduce the number of antibiotic prescriptions among patients presenting to the ED with fever.
A study was conducted with a goal of developing a set of generic quality indicators for the safe and appropriate use of antibiotic agents.
Between 1999 and 2012, Acinetobacter baumannii antibiotic resistance increased in children.
A study evaluated whether uncomplicated UTIs in women could be treated without antibiotics.
Researchers found no association between starting colistin before final culture results and survival at 14 and 28 days.
While macrolides had no direct effect on lung function, their use significantly improved asthma control and quality of life in patients with asthma.
Children deemed low risk who were tested for penicillin allergy tolerated the medication within the following year without serious adverse or allergic reactions.
Use of certain antibiotics may be contributing to the rise of kidney stones among children and adults.
The 36 recalled lots were manufactured by Hospira and marketed by Apotex.
Five-day nitrofurantoin may be a better alternative than single-dose fosfomycin for treating uncomplicated UTI in women.
Findings do not provide evidence that antibiotic mixing, compared with antibiotic cycling with 6-week cycling periods, with third-generation or fourth-generation cephalosporins, piperacillin-tazobactam, and carbapenems reduces the prevalence of carriage with antibiotic-resistant, Gram-negative bacteria in the ICU.
Cross-sectional survey represents the first assessment of antimicrobial prescription practices for prophylaxis in pediatric patients hospitalized worldwide.
The need for innovative new infection prevention programs, antibiotics, and vaccines to prevent and treat antibiotic-resistant infections is an international priority.
Early aggressive action should be taken to prevent the spread of bacteria harboring unusual resistance genes.
The use of acid-suppressive medications and antibiotics during the first 6 months of infancy is tied to subsequent development of allergic disease.
The potential role of vaccinations in combatting antimicrobial resistance (AMR) is currently undervalued. The distribution and development of new vaccines should be priorities in efforts to address the AMR crisis.
The new WHO guidelines restricts antibiotic use in animals for purposes of growth promotion as well as avoidance of use for disease prevention.
Findings from the study did not provide evidence that antibiotic mixing, compared with antibiotic cycling with 6-week cycling periods reduced the prevalence of carriage with antibiotic-resistant, Gram-negative bacteria in the ICU.
Evaluating treatment with meropenem/vaborbactam to piperacillin-tazobactam in patients with complicated UTIs.
The recommendation was made after the FDA reviewed the results of a 10-year follow-up of the CLARICOR trial, which investigated the effects of clarithromycin in patients with stable coronary heart disease.
Investigators identified patient, provider, and practice characteristics associated with antibiotic prescribing in an attempt to determine factors contributing to inappropriate antimicrobial use.
Patient, practice, and provider characteristics are associated with inappropriate antimicrobial prescribing in the outpatient setting.
Study analyzed the trends of nasopharyngeal carriage and antibiotic resistance of Streptococcus pneumoniae, Haemophilus influenza, and Moraxella catarrhalis isolated from young children with acute otitis media during a 16-year period.
Long-term oral macrolide administration may increase macrolide-resistant Propionibacterium acnes.
The CDC has released new data in its Antibiotic Resistance Investment Map on the progress in combating antibiotic resistance.
Developing alternative, non-antibiotic treatments for certain "self-limiting infections" may help preserve the effectiveness of antibiotics.
A new immunotherapy approach has shown promise in it's first-in-human trial for antibiotic-resistant bacteria.
Using whole-genome sequencing, investigators determined that genetically different plasmids from antibiotic-resistant strains emerged in Salmonella enterica serotype Typhimurium in the late 1950s, prior to the release of ampicillin for clinical use.
Experts discuss antibiotic classes in development, which agents holds the most promise, and how to prevent further resistance.
Sign Up for Free e-newsletters
Infectious Disease Advisor Articles
- High Rates of Salmonella Contamination Identified in Kratom
- Influence of Vitamin D in HIV Infection
- Fixed-Dose Bictegravir, Emtricitabine, Tenofovir Alafenamide Is Efficacious HIV-1 Treatment Option
- Ceftazidime/Avibactam an Effective Option in Serious Gram-Negative Infections
- FDA Strengthens Warnings for Fluoroquinolone Antibiotics
- Universal Purchase Programs in the United States May Not Effectively Increase Vaccination Rates
- Tick-Caused Meat Allergy on the Rise in the United States
- Delays in Lactate Testing Associated With Delayed Antibiotics, Increased Mortality in Sepsis
- Prognostic Biomarkers to Guide Antibiotic Therapy in Critically Ill Patients
- Sofosbuvir/Velpatavir Effective for HCV-Infected Liver Transplant Recipients
- Pretreatment Drug Resistance Testing Optimizes Antiretroviral Therapy in INSTI Regimens
- High HCV Sustained Virologic Response Rates With Elbasvir/Grazoprevir in Real-World Setting
- CMS Physician Payment and Policy Changes Proposed for 2019
- FDA: Vibrio parahaemolyticus Illnesses Tied to Fresh Crab Meat From Venezuela
- E. Coli Found in Water at Tennessee Ziplining Facility